We are live on ! Find out more
NGNE icon

Neurogene
NGNE

82 hedge funds and large institutions have $249M invested in Neurogene in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

0% more funds holding

Funds holding: 82 → 82 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.1% less ownership

Funds ownership: 3.28% → 3.18% (-0.1%)

27% less capital invested

Capital invested by funds: $342M → $249M (-$93.1M)

64% less call options, than puts

Call options by funds: $703K | Put options by funds: $1.97M

Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
27
Reduced
24
Closed
9
Calls
$703K
Puts
$1.97M
Net Calls
-$1.26M
Net Calls Change
+$434K

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$5.66M
2
Morgan Stanley
Morgan Stanley
New York
+$3.16M
3
Bank of America
Bank of America
North Carolina
+$1.69M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$832K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$502K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.45M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.71M
3
State Street
State Street
Massachusetts
-$3.8M
4
RG
Redmile Group
California
-$2.19M
5
Goldman Sachs
Goldman Sachs
New York
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
76
Osaic Holdings
Arizona
$10K – – –
PCM
77
Penserra Capital Management
California
$8K – – –
Macquarie Group
78
Macquarie Group
Australia
$5K – – –
GWM
79
Geneos Wealth Management
Colorado
$2K – – –
EVM
80
Eaton Vance Management
Massachusetts
$2K +$2.43K +11 New
Daiwa Securities Group
81
Daiwa Securities Group
Japan
$1K – – –
AIG
82
American International Group
New York
$182 +$10.4K +47 +5%
HS
83
HighVista Strategies
Massachusetts
– -$877K -3,562 Closed
California Public Employees Retirement System
84
California Public Employees Retirement System
California
– -$806K -3,275 Closed
State of Wisconsin Investment Board
85
State of Wisconsin Investment Board
Wisconsin
– -$526K -2,135 Closed
Verition Fund Management
86
Verition Fund Management
Connecticut
– -$313K -1,272 Closed
Victory Capital Management
87
Victory Capital Management
Texas
– -$269K -1,094 Closed
Bank of Montreal
88
Bank of Montreal
Ontario, Canada
– -$26K -107 Closed
Pacer Advisors
89
Pacer Advisors
Pennsylvania
– -$20K -81 Closed
Group One Trading
90
Group One Trading
Illinois
– -$1.11K -5 Closed
Simplex Trading
91
Simplex Trading
Illinois
– -$1.11K -5 Closed
1 2 3
4

NGNE Hedge Fund Activity: Q2 2021 in Review

82 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2021, worth a combined $249M — down 27% from $342M a quarter earlier.

Fund positioning in NGNE was balanced in Q2 2021: 9 funds opened new positions, 9 closed out, 27 added to existing stakes and 24 trimmed.

The largest buyer was Candriam SCA, adding an estimated $5.66M. The largest seller was EcoR1 Capital, cutting an estimated $8.45M.

  • 82 institutional investors held Neurogene (NGNE) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $249M of Neurogene stock for Q2 2021, down 27% quarter-over-quarter.
  • 9 funds opened new Neurogene positions in Q2 2021 and 9 closed out, a net change of 0 holders.
  • The largest Neurogene buyer in Q2 2021 was Candriam SCA, an estimated $5.66M added.
  • The largest Neurogene seller in Q2 2021 was EcoR1 Capital, an estimated $8.45M sold.

Based on aggregated 13F filings for Q2 2021.